| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
100,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,977,498 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
100,920 |
|
|
| Total
Value |
$5,977,498 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-20 |
4 |
AS |
$56.76 |
$383,130 |
D/D |
(6,750) |
15,750 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-06-03 |
4 |
D |
$77.49 |
$544,057 |
D/D |
(7,021) |
47,088 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-15 |
4 |
D |
$94.53 |
$677,686 |
D/D |
(7,169) |
53,606 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-13 |
4 |
D |
$84.50 |
$645,918 |
D/D |
(7,644) |
63,886 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,400 |
15,670 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-15 |
4 |
D |
$78.27 |
$658,877 |
D/D |
(8,418) |
68,745 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-11-14 |
4 |
OE |
$63.10 |
$567,900 |
D/D |
9,000 |
58,135 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-11-14 |
4 |
AS |
$91.62 |
$829,359 |
D/D |
(9,000) |
49,135 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,100 |
29,225 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
62,976 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
65,223 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,586 |
71,530 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,110 |
89,967 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2021-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
36,175 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
42,710 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,380 |
74,266 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
25,380 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
42,090 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2021-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,720 |
72,001 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
31,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-24 |
4 |
A |
$95.61 |
$1,139,396 |
D/D |
11,917 |
53,259 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,940 |
77,163 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-12-03 |
4 |
OE |
$38.59 |
$463,080 |
D/D |
12,000 |
43,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-12-03 |
4 |
S |
$91.01 |
$1,092,161 |
D/D |
(12,000) |
31,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,200 |
55,422 |
0 |
- |
|
174 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
